|
1
|
Wong EA, Wu M. A rare case of flecainide-induced encephalopathy. HeartRhythm Case Rep 2024; 10:201-202. [PMID: 38496743 PMCID: PMC10943541 DOI: 10.1016/j.hrcr.2023.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/19/2024] Open
Affiliation(s)
- Elisabeth A. Wong
- Lifespan Cardiovascular Institute, Division of Cardiovascular Medicine, Rhode Island Hospital, Brown University, Providence, Rhode Island
| | - Michael Wu
- Lifespan Cardiovascular Institute, Division of Cardiovascular Medicine, Rhode Island Hospital, Brown University, Providence, Rhode Island
| |
Collapse
|
|
2
|
Abstract
Genetic variability has recently been implicated in the development of familial epilepsy syndromes and in heterogeneous responses of epilepsy patients to drug treatment. Mutations in distinct proteins have been shown to underlie the development of epilepsy, increase propensity for drug resistance, and alter drug metabolism. Improved understanding of how individual genetic variability may alter the efficacy of pharmacological therapeutic interventions is an important and timely goal. The investigation of relationships between genotype and patient responses to drug treatment is termed pharmacogenomics.
Collapse
Affiliation(s)
- Colleen E Clancy
- Department of Pharmacology, Columbia University, College of Physicians and Surgeons, 630 W. 168th Street, New York, NY 10032, USA.
| | | |
Collapse
|